Our data points to abnormal activation of various inflammasome components in HT patients, with the most significantly altered known pyroptosis mediators being NLRP3 and AIM2, suggesting the potential role of inflammasome-linked pyroptosis in HT pathogenesis. The gene discussed is AIM2; the disease is hematocrit.